On July 29, a recent SEC filing unveiled that Paola M Arbour, EVP at Tenet Healthcare (NYSE:THC) made an insider sell.

What Happened: Arbour's decision to sell 10,878 shares of Tenet Healthcare was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value of the sale is $2,653,144.

As of Wednesday morning, Tenet Healthcare shares are down by 1.43%, currently priced at $260.0.

All You Need to Know About Tenet Healthcare

Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Understanding the Numbers: Tenet Healthcare's Finances

Revenue Growth: Over the 3 months period, Tenet Healthcare showcased positive performance, achieving a revenue growth rate of 4.5% as of 30 June, 2026. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.

Exploring Profitability:

• Gross Margin: With a high gross margin of 83.71%, the company demonstrates effective cost control and strong profitability relative to its peers.
• Earnings per Share (EPS): Tenet Healthcare's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 9.89.

Debt Management: Tenet Healthcare's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.84, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

Valuation Overview:

• Price to Earnings (P/E) Ratio: Tenet Healthcare's P/E ratio of 10.15 is below the industry average, suggesting the stock may be undervalued.
• Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.01, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
• EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 6.04, the company suggests a potential undervaluation, which might be advantageous for value-focused investors.

Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.

Why Insider Transactions Are Important

It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.

When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company’s equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.

A new purchase by a company insider is a indication that they anticipate the stock will rise.

On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.

A Deep Dive into Insider Transaction Codes

In the domain of transactions, investors frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of Tenet Healthcare's Insider Trades.

This article was generated by Benzinga's automated content engine and reviewed by an editor.